Nexus Pharmaceuticals
Tyler Williams, Ph.D., is a seasoned professional in environmental science and analytical chemistry, currently serving as the Quality Control Finished Product Lead and Analytical Chemist at Nexus Pharmaceuticals, Inc. since January 2019. Tyler specializes in surface chemistry to investigate the interactions of emerging contaminants in aquatic environments and evaluates the environmental fate of pharmaceuticals. Prior experience includes roles as a Chemist at the Bureau of Water Quality, where analytical methods for chemical and biological pollutants were performed, and as an Independent Researcher at Minnetrista, focusing on surface water pollution and eutrophication. Educational credentials include a Ph.D. in Environmental Science and a Master’s in Chemistry from Ball State University, complemented by a Bachelor’s in Environmental Management and Chemistry. Skills encompass instrumentation, critical thinking, project planning, and technical writing, showcasing a robust capability in research and laboratory instruction.
Nexus Pharmaceuticals
Nexus Pharmaceuticals is a US-based, family-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality, FDA-approved drugs fulfill a critical, unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most. We are in the process of building Project Tomorrow – a state-of-the-art manufacturing facility in Pleasant Prairie, Wisconsin and only project of its kind in the last 30 years. Read about our commitment to Wisconsin and see our progress at nexuspharma.net/project-tomorrow